Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.30% is 780% above its 4-year average of -0.34%, near the high end of its 4-year range (-1.12%–2.30%).
202.63% above its 12-month average of 0.76%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.70%.
RETURN ON ASSETS (ROA)
2.30%
RETURN ON ASSETS (ROA) AVG TTM
0.76%
RETURN ON ASSETS (ROA) AVG 3Y
-0.18%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+202.63%
CURRENT VS 3Y AVG
+1414.29%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+107.13%
vs the sector median at left
Waystar Holding Corp.
Market Cap
$5.01B
Return on Assets (ROA)
2.30%
TTM Avg
0.76%
3Y Avg
-0.18%
5Y Avg
N/A
Market Cap
$5.05B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$4.95B
Return on Assets (ROA)
-66.02%
TTM Avg
-31.80%
3Y Avg
-35.60%
5Y Avg
-41.38%
Market Cap
$5.15B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$5.16B
Return on Assets (ROA)
-45.20%
TTM Avg
-56.55%
3Y Avg
-55.28%
5Y Avg
-47.01%
Market Cap
$4.83B
Return on Assets (ROA)
-11.66%
TTM Avg
-21.36%
3Y Avg
-19.96%
5Y Avg
-22.39%
Market Cap
$5.18B
Return on Assets (ROA)
-5.44%
TTM Avg
-29.17%
3Y Avg
-28.46%
5Y Avg
-27.49%
Market Cap
$5.21B
Return on Assets (ROA)
4.94%
TTM Avg
1.92%
3Y Avg
-0.50%
5Y Avg
0.13%
Market Cap
$4.78B
Return on Assets (ROA)
-82.32%
TTM Avg
-7.94%
3Y Avg
-19.90%
5Y Avg
-25.16%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waystar Holding Corp. (WAY) | $5.01B | 2.30% | 0.76% | -0.18% | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.05B | 5.08% | 4.88% | 4.58% | 3.44% |
| Erasca, Inc. (ERAS)vs › | $4.95B | -66.02% | -31.80% | -35.60% | -41.38% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.15B | -78.04% | -72.67% | -59.05% | -50.29% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.16B | -45.20% | -56.55% | -55.28% | -47.01% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.83B | -11.66% | -21.36% | -19.96% | -22.39% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.18B | -5.44% | -29.17% | -28.46% | -27.49% |
| Sotera Health Company (SHC)vs › | $5.21B | 4.94% | 1.92% | -0.50% | 0.13% |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.78B | -82.32% | -7.94% | -19.90% | -25.16% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.25B | -17.02% | -21.01% | -19.47% | -13.88% |
ROA
2.3%
ROE
3.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 1.94% |
| 2024-12-31 | -0.42% |
| 2023-12-31 | -1.12% |
| 2022-12-31 | -1.10% |
| 2021-12-31 | -0.99% |
